Health ❯ Cancer

Multiple Myeloma

Treatment Diagnosis Symptoms Patti Scialfa Health Challenges Immunotherapy Jan Vandersloot Treatment Challenges Remission Bone Marrow Illness Bone Marrow Cancer Autologous Stem Cell Transplant Genomic Risk Assessment Diagnostics Ferroptosis Treatment Advances Prognosis Personal Loss Stage 3 Cancer Chronic Illness Early Diagnosis Patient Outcomes Clinical Presentation Clinical Research Immune System Biological Mechanisms Lung Cancer Immunology Causes Research Treatment Options Survival Rate

Gilead to Acquire Arcellx for Up to $7.8 Billion to Gain Full Control of CAR-T Anito-Cel

The purchase secures full control of anito-cel, a BCMA-directed cell therapy under FDA review with a December 23 action date.

U.S. Cohort Study Finds Men Present With More Advanced Multiple Myeloma

Immune Atlas Sharpens Myeloma Risk Prediction as Dual-Target CAR T Counters BCMA Loss

New Genomic Score Enhances Prediction of Multiple Myeloma Progression